SEK28.8 1.0 3.6%
Last Trade - 8:33am
| Market Cap | ÂŁ27.2m |
| Enterprise Value | ÂŁ25.5m |
| Revenue | ÂŁ348k |
| Position in Universe | 1282nd / 1869 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 1.42 | 2.64 | 1.05 | 1.23 | 2.49 | +15.1% | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Fluicell AB is a Sweden-based company within healthcare industry. It commercializes a product portfolio for processing and studying of individual cells, primarily in the field of drug development. The Company’s products comprise research tools BioPen and Dynaflow Resolve. Tools enable researchers to study, process and measure drug impact on individual cells. Also, the Company develops bioprinting technology Biopixlar Retina in both two-dimensional (2D) and three-dimensional (3D) options. Biopixlar Retina creates complex tissue-like structures with control over positioning of individual cells.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| Public Since | April 18, 2018 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Index | |
| Exchange | OMX Nordic Exchange Stockholm |
| Shares in Issue | 11,459,908 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Flojelbergsgatan 8C Molndal, GOTEBORG, 431 37, Sweden |
| Web | http://fluicell.com/ |
| Phone | +46 31 3607481 |
| Contact | () |
| Auditors | KPMG AB |
As of 8:33am, shares in Fluicell AB are trading at SEK28.8, giving the company a market capitalisation of ÂŁ27.2m. This share price information is delayed by 15 minutes.
Shares in Fluicell AB are currently trading at SEK28.8 and the price has moved by 0.122k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Fluicell AB price has moved by 0.121k% over the past year.
There are no analysts currently covering Fluicell AB.
Fluicell AB is scheduled to issue upcoming financial results on the following dates:
Fluicell AB does not currently pay a dividend.
Fluicell AB does not currently pay a dividend.
Fluicell AB does not currently pay a dividend.
To buy shares in Fluicell AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Fluicell AB are currently trading at SEK28.8, giving the company a market capitalisation of ÂŁ27.2m.
Here are the trading details for Fluicell AB:
Based on an overall assessment of its quality, value and momentum, Fluicell AB is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for Fluicell AB.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fluicell AB. Over the past six months, the relative strength of its shares against the market has been 0.138k%. At the current price of SEK28.8, shares in Fluicell AB are trading at 0.110k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Fluicell AB.
Fluicell AB's management team is headed by:
Here are the top five shareholders of Fluicell AB based on the size of their shareholding:
